Delivery Order SPE2DB20D1100-SPE2DB25FA1U4
Award Date
1/21/25
Potential Completion Date
2/11/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, and has a ceiling value of $4,115.58. The contract is a firm fixed-price arrangement with a completion date of February 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the provision of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract has a completion date of February 27, 2025 and is a firm fixed-price delivery order contract. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of TESTOPEL 75 MG PELLETS. The $3,978.09 contract has a completion date of March 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and a for-profit organization. This award is issued under an indefinite delivery contract (IDC) with DLA, with a potential value of $999,999,999.00 and a performance period...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,978.08, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. No...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $3,978.09, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to DLA facilities. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDRX6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, with a ceiling value of $8,231.16 and a period of performance through January 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,956.18 and a completion date of September 24, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $7,956.18 firm fixed price delivery order is for the supply of 100 units of the medication TESTOPEL 75 MG PELLETS. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up...
This federal contract award, with the identification number SPE2DB22D3004 and SPE2DB23FPV94, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical with AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the supply of 100 units of Testopel 75 mg pellets, a medical product, with a ceiling value of $3,978.08 and a completion date of May 4, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
The Defense Logistics Agency awarded a $15,912 delivery order to Amerisourcebergen Drug Corporation for TESTOPEL 75 MG PELLETS 100S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the specified pharmaceutical product to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Funding is being provided by DLA to support its medical supply chain requirements. No set aside designation or subcontractors were identified. This...